Literature DB >> 3057667

Anal fissure and stenosis.

M J Notaras1.   

Abstract

Fissure in ano is a simple condition that causes considerable discomfort. The acute forms should be treated by conservative nonsurgical regimens initially. If the patient finds the symptoms intolerable, or if the fissure demonstrates signs of chronicity, then lateral subcutaneous sphincterotomy is recommended as an ideal simple surgical procedure that has the advantages of a low complication rate and low morbidity. It is easily performed under local anesthesia and does not require hospitalization. It is gratifyingly satisfying for both the patient and surgeon. Certain types of anal stenosis, especially those following hemorrhoidectomy, are successfully managed by lateral sphincterotomy combined with postoperative anal dilatation. This approach avoids the more complicated plastic anal procedures that have been used in the past.

Entities:  

Mesh:

Year:  1988        PMID: 3057667     DOI: 10.1016/s0039-6109(16)44698-0

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  4 in total

1.  Anorectal Disease.

Authors:  P Huber; S Gregorcyk
Journal:  Curr Treat Options Gastroenterol       Date:  2000-06

2.  Glyceryl trinitrate ointment (0.25%) and anal cryothermal dilators in the treatment of chronic anal fissures.

Authors:  Michele Schiano di Visconte; Gabriele Munegato
Journal:  J Gastrointest Surg       Date:  2009-04-15       Impact factor: 3.452

Review 3.  The management of patients with primary chronic anal fissure: a position paper.

Authors:  D F Altomare; G A Binda; S Canuti; V Landolfi; M Trompetto; R D Villani
Journal:  Tech Coloproctol       Date:  2011-05-03       Impact factor: 3.781

4.  Herbal medicine AnoSpray suppresses proinflammatory cytokines COX-2 and RANTES in the management of hemorrhoids, acute anal fissures and perineal wounds.

Authors:  Ashwin Porwal; Gopal C Kundu; Gajanan Bhagwat; Ramesh Butti
Journal:  Exp Ther Med       Date:  2021-11-25       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.